Literature DB >> 19656971

Influenza A virus M1 blocks the classical complement pathway through interacting with C1qA.

Junjie Zhang1,2, Gang Li1,2, Xiaoling Liu3,1, Zengfu Wang3,1, Wenjun Liu3, Xin Ye2.   

Abstract

The matrix (M1) protein of influenza A virus is a conserved multifunctional protein that plays essential roles in regulating the viral life cycle. This study demonstrated that M1 is able to interact with complement C1qA and plays an important inhibitory function in the classical complement pathway. The N-terminal domain of M1 protein was required for its binding to the globular region of C1qA. As a consequence, M1 blocked the interaction between C1qA and heat-aggregated IgG in vitro and inhibited haemolysis. It was shown that M1 protein prevented the complement-mediated neutralization of influenza virus in vitro. In addition, studies on mice indicated that the administration of M1 could promote a higher virus propagation rate in lung and shortened survival of mice infected with the virus. Taken together, these results suggest strongly that the M1 protein plays a critical role in protecting influenza virus from the host innate immune system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19656971     DOI: 10.1099/vir.0.014316-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  28 in total

1.  Crystal structure of zebrafish complement 1qA globular domain.

Authors:  Hongyu Yuan; Rong Chen; Mansoor Tariq; Yanjie Liu; Yaping Sun; Chun Xia
Journal:  Protein Sci       Date:  2016-09-13       Impact factor: 6.725

2.  Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compared to immunization with gD alone.

Authors:  Sita Awasthi; John M Lubinski; Carolyn E Shaw; Shana M Barrett; Michael Cai; Fushan Wang; Michael Betts; Susan Kingsley; Daniel J Distefano; John W Balliet; Jessica A Flynn; Danilo R Casimiro; Janine T Bryan; Harvey M Friedman
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

3.  The complement C1qA enhances retinoic acid-inducible gene-I-mediated immune signalling.

Authors:  Yetao Wang; Xiaomei Tong; Junjie Zhang; Xin Ye
Journal:  Immunology       Date:  2012-05       Impact factor: 7.397

4.  Cyclin T1/CDK9 interacts with influenza A virus polymerase and facilitates its association with cellular RNA polymerase II.

Authors:  Junjie Zhang; Gang Li; Xin Ye
Journal:  J Virol       Date:  2010-10-13       Impact factor: 5.103

5.  Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

Authors: 
Journal:  Sci Immunol       Date:  2021-05-13

6.  Crystallization and preliminary crystallographic studies of the complement 1qA globular domain from zebrafish, Dare-C1qAgD.

Authors:  Hongyu Yuan; Rong Chen; Yanjie Liu; Mansoor Tariq; Yaping Sun; Chun Xia
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-06-18       Impact factor: 1.056

Review 7.  Humoral innate immune response and disease.

Authors:  Stephanie N Shishido; Sriram Varahan; Kai Yuan; Xiangdong Li; Sherry D Fleming
Journal:  Clin Immunol       Date:  2012-06-18       Impact factor: 3.969

Review 8.  Complement and viral pathogenesis.

Authors:  Kristina A Stoermer; Thomas E Morrison
Journal:  Virology       Date:  2011-02-02       Impact factor: 3.616

Review 9.  Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease.

Authors:  Nicole Ng; Charles A Powell
Journal:  J Clin Med       Date:  2021-05-19       Impact factor: 4.241

10.  Complement C5 activation during influenza A infection in mice contributes to neutrophil recruitment and lung injury.

Authors:  Cristiana C Garcia; Wynne Weston-Davies; Remo C Russo; Luciana P Tavares; Milene A Rachid; José C Alves-Filho; Alexandre V Machado; Bernhard Ryffel; Miles A Nunn; Mauro M Teixeira
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.